Disproportional response: a small company's current business is visibly outgrowing its own size
The model's full reasoning — Q3 2022 call → NOWe need to determine if management conveys that the business currently happening is disproportionately large relative to the company's small size. Look for statements about current activity, demand, commitments, or volumes that are large compared to the company's size. The transcript mentions recurring revenue increase, customers coming online, a customer doubling spend, a customer increasing transactions from 600k to 2 million, etc. But does management explicitly contrast the small size of the company with the scale of what's arriving? They mention "robust pipeline" but that's future. They mention "we are very encouraged by our ability to continually increase our recurring revenue which has increased $0.3 million in comparison to the first 9 months of last year to $7.1 million year-to-date." That's a modest increase. They mention "a couple of government customers receive approved to operate status after extended pilot phases and in one case, a sizable delay." That's about delays. They mention "one of our long-standing customers has almost doubled their spend with us." That's a single customer but not necessarily disproportionate to company size. They mention "We just recently signed a customer that last year or this current year that just ended had about 600,000, 700,000 transactions as they are committed minimal. They went over it. And so we renewed them for next year, 2 million transactions. So almost a 3x increase of them." That's a specific customer increase, but does that indicate the company is small relative to what's arriving? The company's revenue is $3 million per quarter. A customer doubling spend might be significant but not necessarily "disproportionately large" relative to the whole company. The question asks if management conveys that the business is visibly outgrowing the company's own current size and setup. They talk about launching AwareID, but that's new. They talk about a robust pipeline, but that's future. They talk about delays. They don't explicitly say "we are small and this is huge relative to us." They do mention "we are confident that we can accelerate adoption" but that's forward-looking. The key is whether management describes current activity, demand, or commitments arriving at a scale that is large relative to how small the company still is.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| KOPN | Kopin Corporation | Q4 2023 | 2024-03-14 | C+ |
| TMCI | Treace Medical Concepts, Inc. | Q2 2022 | 2022-08-13 | B+ |
| VNRX | VolitionRx Limited | Q1 2022 | 2022-05-12 | F |
| FLUX | Flux Power Holdings, Inc. | Q2 2022 | 2022-02-10 | D |
VNRX · Q1 2022 → YESThe question is: Does management convey that the business the company is doing RIGHT NOW is visibly outgrowing the company's own current size and setup? That current activity, demand, or commitments a...YES The transcript shows management explicitly describing the Heska deal (already signed and with $10M upfront received) as a long-term, multi-year commitment that will generate ongoing kit/component revenue "significantly greater" than the $28M milestones, with "millions of tests" expected each year — all while repeatedly noting the company is "not a big company" and that this is "the beginning of our commercial journey" after 12 years of R&D. They contrast this with their tiny current revenue ($114k) and cash position, framing the new activity as disproportionately large relative to their size.
TMCI · Q2 2022 → YESThe question is: Does management convey that the business the company is doing RIGHT NOW is visibly outgrowing the company's own current size and setup? That current activity, demand, or commitments a...YES Management explicitly describes the business as outgrowing its current setup in present-tense terms: they are “once again in the process of relocating to a larger headquarters facility” to meet “increased requirements” for training, R&D, warehousing, and infrastructure; the direct sales force has grown 52% to 123 quota-carrying reps and is already trending above the year-end 70% direct mix goal; surgeon penetration has reached 20% of the estimated 10,000 U.S. foot-and-ankle surgeons while procedure penetration is 4.6% of the 450,000 annual U.S.
KOPN · Q4 2023 → YESThe question is: Does management convey that the business the company is doing RIGHT NOW is visibly outgrowing the company's own current size and setup? That current activity, demand, or commitments a...YES The transcript shows management describing current activity (a $55 million backlog, a $20.5 million new order, follow-on orders, and tripled weapon-site volume expected in 2024) as large relative to the company’s still-small size and setup. They explicitly note the backlog is a “record level 10 years,” that they had to extend the holiday shutdown and retool the plant for a “significant increase in production,” and that they are “buying to that level of volume today” while remaining conservative on guidance.